Pharmanutra Logo

Pharmanutra

PHN | XMIL

Overview

Corporate Details

ISIN(s):
IT0005274094
LEI:
815600F8217BC7733697
Country:
Italy
Address:
VIA CAMPODAVELA, 1, 56122 PISA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmaNutra S.p.A., established in 2003, is an Italian company specializing in the research, development, and marketing of nutraceutical products, food supplements, and medical devices. The company focuses on creating innovative and scientifically-backed solutions, particularly for nutritional deficiencies in minerals and vitamins, as well as for muscle and joint health. PharmaNutra manages the entire production cycle, from proprietary raw materials to the finished product, ensuring high standards of efficacy and safety. The group also develops and sells pharmaceuticals, distinguishing itself through a strong emphasis on scientific research and innovation.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Pharmanutra. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 18:05
Regulatory News Service
PR PHARMANUTRA SPA - Sidevit B12 sales
English 465.8 KB
2025-08-04 18:04
Earnings Release
CS PHARMANUTRA SPA - Vendite Sidevit B12
Italian 259.1 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Lancio ApportAL Boost
Italian 189.4 KB
2025-06-03 08:00
Regulatory News Service
Pharmanutra: Launch of ApportAL Boost
English 241.0 KB
2025-05-27 10:47
Investor Presentation
MIDCAP Road Show - Paris
English 3.4 MB
2025-05-15 15:26
Registration Form
Statuto sociale aggiornato
Italian 295.1 KB
2025-05-15 15:25
Pre-Annual General Meeting Information
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
Italian 9.4 MB
2025-05-15 15:23
Post-Annual General Meeting Information
Pharmanutra: Avviso deposito verbale Assemblea e Statuto aggiornato_Filing of m…
Italian 172.3 KB
2025-05-14 11:46
Quarterly Report
Interim Management report as at March 31st, 2025
English 1.7 MB
2025-05-14 11:45
Management Discussion and Analysis
Resoconto Intermedio di gestione al 31 Marzo 2025
Italian 1.4 MB
2025-05-14 11:44
Report Publication Announcement
Avviso deposito Rendiconto Intermedio di gestione al 31 marzo 2025 || Notice of…
Italian 177.0 KB
2025-05-12 17:30
Earnings Release
Pharmanutra: CdA approva il Resoconto intermedio di gestione al 31 marzo 2025
Italian 282.7 KB
2025-05-12 17:30
Quarterly Report
Pharmanutra: BoD approves the Intermin management report as of March 31, 2025
English 349.0 KB
2025-05-06 17:02
Director's Dealing
Allegato 3F - Aprile 2025
Italian 92.0 KB
2025-04-22 16:41
Post-Annual General Meeting Information
PHARMANUTRA: Voting Summary Report
English 341.1 KB

Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmanutra via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK